| Patent | Date |
|---|
WDR5 inhibitors and modulators
Grant 10,844,044 - Alvarado , et al. November 24, 2 | 2020-11-24 |
WDR5-MLL1 inhibitors and modulators
Grant 10,807,959 - Gogliotti , et al. October 20, 2 | 2020-10-20 |
Wdr5 Inhibitors And Modulators
App 20200102288 - Alvarado; Joseph R. ; et al. | 2020-04-02 |
Wdr5-mll1 Inhibitors And Modulators
App 20200055824 - Gogliotti; Rocco D. ; et al. | 2020-02-20 |
WDR5 inhibitors and modulators
Grant 10,160,763 - Fesik , et al. Dec | 2018-12-25 |
Wdr5 Inhibitors And Modulators
App 20180086767 - Fesik; Stephen W. ; et al. | 2018-03-29 |
Menin-MLL inhibitors and methods of use thereof
Grant 9,212,180 - Grembecka , et al. December 15, 2 | 2015-12-15 |
Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 9,192,603 - Conn , et al. November 24, 2 | 2015-11-24 |
mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 9,180,192 - Conn , et al. November 10, 2 | 2015-11-10 |
Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 9,163,015 - Conn , et al. October 20, 2 | 2015-10-20 |
Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 9,108,963 - Conn , et al. August 18, 2 | 2015-08-18 |
Menin-mll Inhibitors And Methods Of Use Thereof
App 20140371239 - Grembecka; Jolanta ; et al. | 2014-12-18 |
MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 8,779,157 - Conn , et al. July 15, 2 | 2014-07-15 |
Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same
Grant 8,697,691 - Conn , et al. April 15, 2 | 2014-04-15 |
Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 8,658,650 - Conn , et al. February 25, 2 | 2014-02-25 |
Heterocyclic Sulfone MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction
App 20130158078 - Conn; P. Jeffrey ; et al. | 2013-06-20 |
Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction
App 20130096110 - Conn; P. Jeffrey ; et al. | 2013-04-18 |
Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction
App 20130065895 - Conn; P. Jeffrey ; et al. | 2013-03-14 |
Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20130040944 - Conn; P. Jeffrey ; et al. | 2013-02-14 |
Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20120245153 - Conn; P. Jeffrey ; et al. | 2012-09-27 |
Substituted 1,1,3,1-tetraoxidobenzo[d][1,3,2]dithiazoles As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20110319429 - Conn; P. Jeffrey ; et al. | 2011-12-29 |
Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate Analogs As Selective M1 Agonists And Methods Of Making And Using Same
App 20110172227 - Conn; P. Jeffrey ; et al. | 2011-07-14 |
Piperidine Derivatives
App 20100120858 - Caprathe; Bradley W. ; et al. | 2010-05-13 |
Isothiazolones
Grant 5,620,997 - Bolton , et al. April 15, 1 | 1997-04-15 |
| 